Mark Hillman's PFE Position Overview
Mark Hillman (via Hillman Capital Management, Inc.) currently holds 216.6K shares of Pfizer Inc. (PFE) worth $5.52 M, representing 3.21% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Mark Hillman has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 88.9K shares. Largest reduction occurred in Q1 2025, reducing 78.4K shares.
Analysis based on 13F filings available since 2013 Q2
Mark Hillman's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Mark Hillman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +23,983 | Add 0.00% | 23,982 | $29.23 |
| Q4 2019 | +83,708 | Add 0.00% | 83,707 | $39.18 |
| Q1 2020 | +6,032 | Add 7.21% | 89,739 | $32.64 |
| Q2 2020 | +7 | Add 0.01% | 89,746 | $32.70 |
| Q3 2020 | -110 | Reduce 0.12% | 89,636 | $36.70 |
| Q4 2020 | +18,832 | Add 21.01% | 108,468 | $36.81 |
| Q1 2021 | +60,187 | Add 55.49% | 168,655 | $36.23 |
| Q2 2021 | +450 | Add 0.27% | 169,105 | $39.16 |
| Q3 2021 | +7,427 | Add 4.39% | 176,532 | $43.01 |
| Q4 2021 | -176,532 | Sold Out | 176,532 | $0.00 |
| Q4 2023 | +187,795 | New Buy | 187,795 | $28.79 |
| Q1 2024 | +44,347 | Add 23.61% | 232,142 | $27.75 |
| Q2 2024 | -992 | Reduce 0.43% | 231,150 | $27.98 |
| Q3 2024 | -91 | Reduce 0.04% | 231,059 | $28.94 |
| Q4 2024 | +88,910 | Add 38.48% | 319,969 | $26.53 |
| Q1 2025 | -78,388 | Reduce 24.50% | 241,581 | $25.34 |
| Q2 2025 | -6,953 | Reduce 2.88% | 234,628 | $24.24 |
| Q3 2025 | -18,076 | Reduce 7.70% | 216,552 | $25.48 |
Mark Hillman's Pfizer Investment FAQs
Mark Hillman first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 23,982 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman has held Pfizer Inc. (PFE) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman's largest addition to Pfizer Inc. (PFE) was in Q4 2023, adding 187,795 shares worth $5.41 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mark Hillman's firm, Hillman Capital Management, Inc., owns 216,552 shares of Pfizer Inc. (PFE), valued at approximately $5.52 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Pfizer Inc. (PFE) represents approximately 3.21% of Mark Hillman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mark Hillman's peak holding in Pfizer Inc. (PFE) was 319,969 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.